Premium Information is available for this item - Upgrade for $1 a day
6505-01-317-0302
Usp Flutamide Capsules
6505013170302 013170302 NDC00085-0525-05 EULEXIN EULEXIN CAPSULES
INC: 66744 Flutamide Capsules
May 2023
12
Marketplace 6505-01-317-0302
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-317-0302 5+ Documents (More...)
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-306-1728 Usp Flutamide Capsules 6505013061728 EULEXIN
) Canceled/Obsolete RNCC 5 RNVC 9 DAC 4 EULEXIN CAPSULES 1F095 - Schering-Plough Corporation (Obsolete
on 19 Aug 1989 Data Last NSN Created on 19 Aug 1989 Data Last NSN Created on 19 Aug 1989 Data Last EULEXIN
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-317-0302 Usp Flutamide Capsules 6505013170302 EULEXIN
/fsg-65/fsc-6505/us 6505-01-317-0302 Usp Flutamide Capsules 6505013170302 your Account Upgrade 6505-
01-317-0302Usp Flutamide Capsules6505013170302 013170302 NDC00085-0525-05 EULEXIN EULEXIN CAPSULES Managed
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-317-0302 Usp Flutamide Capsules 6505013170302 EULEXIN CAPSULES
Usp Flutamide Capsules 6505013771443,EULEXIN a day Upgrade Usp Flutamide Capsules 6505013771443,EULEXIN
Upgrade Usp Flutamide Capsules 6505013771443,EULEXIN https//www.nsnlookup.com /fsg-65/fsc-6505/br 6505
Usp Flutamide Capsules 6505013771443,EULEXIN6505013771443,EULEXIN https//www.nsnlookup.com /fsg-65/fsc
Restrictions 6505-01-317-0302
6505-01-317-0302 is a Usp Flutamide Capsules that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item has been determined to be hazardous and information is contained in the Hazardous Materials Information Resource System (HMIRS). This item does not contain a precious metal.
Import and Export 6505-01-317-0302
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-317-0302
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-317-0302
- Part Number
- Manufacturer
- Status
- NDC00085-0525-05
- Manufacturer
- 1F095 - Schering-Plough Corporation (Obsolete)
- Original Design
- Original Design
- EULEXIN
- 1F095 - Schering-Plough Corporation (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
- EULEXIN CAPSULES
- 1F095 - Schering-Plough Corporation (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-01-317-0302
- Characteristic
- Specifications
- FIIG
- Specifications
- A510U0
- Capsule Type [AKJC]
- Any Acceptable
- Capsule Content Form [CQLS]
- Any Acceptable
- Active Medicament Medicinal Strength [AKJA]
- 125.000 Milligrams Flutamide Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Capsule Primary Container Content Quantity [CYLZ]
- 500.000
- Protective Storage Feature [AJCN]
- Antineoplastic Drug
- Part Name Assigned By Controlling Agency [CXCY]
- Eulexin Capsules
Similar Supply Items to 6505-01-317-0302
Freight Information 6505-01-317-0302
6505-01-317-0302 has freight characteristics managed by the Bonneville Power Administration.. 6505-01-317-0302 has a variance between NMFC and UFC when transported by rail and the description should be consulted.